These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25638764)

  • 21. Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial.
    Sanz MA; López J; Lahuerta JJ; Rovira M; Batlle M; Pérez C; Vázquez L; Julià A; Palau J; Gutiérrez M; Capote FJ; Ramos F; Benlloch L; Larrea L; Jarque I;
    J Antimicrob Chemother; 2002 Jul; 50(1):79-88. PubMed ID: 12096010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of febrile neutropenic attacks of pediatric hematology-oncology patients.
    Kar YD; Özdemir ZC; Bör Ö
    Turk Pediatri Ars; 2017 Dec; 52(4):213-220. PubMed ID: 29483801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized prospective multicentre trial of cefpirome versus piperacillin-tazobactam in febrile neutropenia.
    Bauduer F; Cousin T; Boulat O; Rigal-Huguet F; Molina L; Fegueux N; Jourdan E; Boiron JM; Reiffers J;
    Leuk Lymphoma; 2001 Jul; 42(3):379-86. PubMed ID: 11699402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for adverse outcomes and multidrug-resistant Gram-negative bacteraemia in haematology patients with febrile neutropenia in a Singaporean university hospital.
    Poon LM; Jin J; Chee YL; Ding Y; Lee YM; Chng WJ; Chai LY; Tan LK; Hsu LY
    Singapore Med J; 2012 Nov; 53(11):720-5. PubMed ID: 23192498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of High Risk Patients with Febrile Neutropenia at a Tertiary Care Center.
    Osmani AH; Jabbar AA; Gangwani MK; Hassan B
    Asian Pac J Cancer Prev; 2017 Oct; 18(10):2741-2745. PubMed ID: 29072402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Microbiological characteristics of pathogens causing bacteremia among hospitalized pediatric oncology patients with fever and neutropenia].
    Leibson T; Ben-Shimol S; Hazan G; Fruchtman Y; Kapelushnik J; Greenberg D
    Harefuah; 2012 Oct; 151(10):592-6, 603-4. PubMed ID: 23316669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors predicting outcome in high risk febrile neutropenia in patients receiving intensive chemotherapy for acute sleukemia: A prospective, observational study from South India.
    Rajendranath R; Balasubramaniyum VK; Vijayakumar V; Ganesan P; Tenali GS
    Indian J Cancer; 2014; 51(4):481-6. PubMed ID: 26842171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chemotherapy-induced febrile neutropenia: About 186 episodes. Clinical, microbiological and therapeutic characteristics].
    Masmoudi S; Khanfir A; Maalej-Mezghan S; Hammami A; Frikha M
    Tunis Med; 2015 Apr; 93(4):217-22. PubMed ID: 26375737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microbiological spectrum and susceptibility patterns of pathogens causing bacteraemia in paediatric febrile neutropenic oncology patients: comparison between two consecutive time periods with use of different antibiotic treatment protocols.
    Greenberg D; Moser A; Yagupsky P; Peled N; Hofman Y; Kapelushnik J; Leibovitz E
    Int J Antimicrob Agents; 2005 Jun; 25(6):469-73. PubMed ID: 15890499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Piperacillin-tazobactam as empiric monotherapy in febrile neutropenic patients with haematological malignancies.
    Hazel DL; Graham J; Dickinson JP; Newland AC; Kelsey SM
    J Chemother; 1997 Aug; 9(4):267-72. PubMed ID: 9269607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imipenem-cilastatin versus piperacillin-tazobactam as monotherapy in febrile neutropenia.
    Vural S; Erdem E; Gulec SG; Yildirmak Y; Kebudi R
    Pediatr Int; 2010 Apr; 52(2):262-7. PubMed ID: 19744230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Pattern of Microorganisms and Drug Susceptibility in Pediatric Oncologic Patients with Febrile Neutropenia.
    Jungrungrueng T; Anugulruengkitt S; Lauhasurayotin S; Chiengthong K; Poparn H; Sosothikul D; Techavichit P
    J Pathog; 2021; 2021():6692827. PubMed ID: 33854800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes.
    Jeddi R; Achour M; Amor RB; Aissaoui L; Bouterâa W; Kacem K; Lakhal RB; Abid HB; BelHadjAli Z; Turki A; Meddeb B
    Hematology; 2010 Feb; 15(1):28-32. PubMed ID: 20132659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective randomized trial comparing piperacillin/tazobactam with meropenem as empirical antibiotic treatment of febrile neutropenic children and adolescents with hematologic and malignant disorders.
    Sano H; Kobayashi R; Suzuki D; Hori D; Kishimoto K; Kobayashi K
    Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27873451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fluoroquinolone prophylaxis utility during chemotherapy-induced severe neutropenia in patients with acute leukemia, with fluoroquinolone resistance high prevalence, in a reference hospital in Mexico City].
    Ugarte-Torres A; Villasis-Keever A; Hernández-Bribiesca ME; Crespo-Solis E; Ruiz-Palacios GM; Sifuentes-Osornio J; Ponce-De-León-Garduño A
    Rev Invest Clin; 2006; 58(6):547-54. PubMed ID: 17432285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of febrile neutropenia in solid organ malignancies following chemotherapy.
    Lakshmaiah KC; Abhayakumar SM; Shetty R; Loknath D; Jayashree RS; Govindbabu K
    J Cancer Res Ther; 2014; 10(3):540-3. PubMed ID: 25313735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of febrile neutropenia episodes in children, with a piperacillin-tazobactam and netilmicin combination].
    Fouyssac F; Salmon A; Mansuy L; Schmitt C; Bordigoni P; Chastagner P
    Med Mal Infect; 2005 Jun; 35(6):357-62. PubMed ID: 15982848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pattern of infection, therapy, outcome and risk stratification of patients with febrile neutropenia in a tertiary care oncology hospital in India.
    Noronha V; Joshi A; Patil VM; Bhosale B; Muddu VK; Banavali S; Kelkar R; Prabhash K
    Indian J Cancer; 2014; 51(4):470-4. PubMed ID: 26842166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Febrile neutropenia in paediatric peripheral blood stem cell transplantation, in -vitro sensitivity data and clinical response to empirical antibiotic therapy.
    Ansari SH; Nasim S; Ahmed A; Irfan M; Ishaque A; Farzana T; Panjwani VK; Taj M; Shamsi TS
    J Coll Physicians Surg Pak; 2006 Nov; 16(11):704-8. PubMed ID: 17052420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of two different anti-infectious approaches after high-dose chemotherapy and autologous stem cell transplantation for hematologic malignancies in a 12-year period in British Hospital, Uruguay.
    Oliver AC; Riva E; Mosquera R; Galeano S; Pierri S; Bello L; Caneiro A; Gai R; Miller A; Muxi P
    Ann Hematol; 2020 Apr; 99(4):877-884. PubMed ID: 32062742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.